Q9Z1S3
Gene name |
Rasgrp1 (Rasgrp) |
Protein name |
RAS guanyl-releasing protein 1 |
Names |
Calcium and DAG-regulated guanine nucleotide exchange factor II , CalDAG-GEFII , Ras guanyl-releasing protein |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:19419 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
201-437 (Ras guanine-nucleotide exchange factors catalytic domain) |
Relief mechanism |
Ligand binding, PTM |
Assay |
|
Target domain |
463-505 (EF domain) |
Relief mechanism |
Ligand binding, PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell systems, 2, 89-100
- Canault M et al. (2020) "RasGRP2 Structure, Function and Genetic Variants in Platelet Pathophysiology", International journal of molecular sciences, 21,
- Ren J et al. (2016) "A negative-feedback loop regulating ERK1/2 activation and mediated by RasGPR2 phosphorylation", Biochemical and biophysical research communications, 474, 193-198
- Czikora A et al. (2016) "Structural Basis for the Failure of the C1 Domain of Ras Guanine Nucleotide Releasing Protein 2 (RasGRP2) to Bind Phorbol Ester with High Affinity", The Journal of biological chemistry, 291, 11133-47
- Iwig JS et al. (2013) "Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1", eLife, 2, e00813
Autoinhibited structure

Activated structure

1 structures for Q9Z1S3
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q9Z1S3-F1 | Predicted | AlphaFoldDB |
49 variants for Q9Z1S3
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3392084572 | 16 | H>L | No | EVA | |
rs3392112566 | 16 | H>Y | No | EVA | |
rs3391934371 | 18 | S>A | No | EVA | |
rs3392112585 | 19 | R>S | No | EVA | |
rs3392112614 | 20 | A>S | No | EVA | |
rs3392000432 | 22 | P>A | No | EVA | |
rs3392098425 | 23 | K>I | No | EVA | |
rs3388577301 | 55 | H>N | No | EVA | |
rs3388577549 | 57 | A>V | No | EVA | |
rs3388575042 | 68 | S>R | No | EVA | |
rs3388570416 | 139 | M>I | No | EVA | |
rs3388565805 | 203 | H>R | No | EVA | |
rs3388577332 | 240 | E>D | No | EVA | |
rs3388576110 | 242 | P>L | No | EVA | |
rs3388572290 | 298 | I>F | No | EVA | |
rs3388577307 | 300 | G>E | No | EVA | |
rs3388580945 | 302 | C>S | No | EVA | |
rs3388576047 | 323 | V>* | No | EVA | |
rs3388577319 | 353 | P>T | No | EVA | |
rs3388565818 | 358 | H>Q | No | EVA | |
rs3388572306 | 361 | D>N | No | EVA | |
rs3388583099 | 364 | S>P | No | EVA | |
rs3388577620 | 371 | D>N | No | EVA | |
rs3388583106 | 393 | L>S | No | EVA | |
rs3388575058 | 420 | Y>F | No | EVA | |
rs3388565795 | 424 | D>N | No | EVA | |
rs3392084535 | 433 | R>P | No | EVA | |
rs3388579481 | 437 | N>I | No | EVA | |
rs3388570498 | 465 | K>Q | No | EVA | |
rs3388576447 | 490 | I>M | No | EVA | |
rs3388577629 | 508 | V>M | No | EVA | |
rs3388576425 | 534 | S>Y | No | EVA | |
rs3388580888 | 539 | G>D | No | EVA | |
rs3388572253 | 548 | T>N | No | EVA | |
rs3388576095 | 566 | I>F | No | EVA | |
rs3388572250 | 574 | D>N | No | EVA | |
rs3388573412 | 576 | G>W | No | EVA | |
rs3388577311 | 589 | F>L | No | EVA | |
rs3388579430 | 603 | E>* | No | EVA | |
rs3388573410 | 604 | N>I | No | EVA | |
rs3388579441 | 611 | M>I | No | EVA | |
rs3388577589 | 634 | Q>L | No | EVA | |
rs243390638 | 638 | I>V | No | EVA | |
rs222296530 | 686 | T>A | No | EVA | |
rs222296530 | 686 | T>P | No | EVA | |
rs3388576478 | 716 | A>S | No | EVA | |
rs3388575419 | 718 | V>I | No | EVA | |
rs3388579431 | 741 | L>F | No | EVA | |
rs3388576416 | 782 | S>G | No | EVA |
No associated diseases with Q9Z1S3
Functions
4 GO annotations of cellular component
Name | Definition |
---|---|
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
Golgi membrane | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
6 GO annotations of molecular function
Name | Definition |
---|---|
calcium ion binding | Binding to a calcium ion (Ca2+). |
diacylglycerol binding | Binding to a diacylglycerol, a diester of glycerol and two fatty acids. |
guanyl-nucleotide exchange factor activity | Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. |
identical protein binding | Binding to an identical protein or proteins. |
phosphatidylcholine binding | Binding to a phosphatidylcholine, a glycophospholipid in which a phosphatidyl group is esterified to the hydroxyl group of choline. |
zinc ion binding | Binding to a zinc ion (Zn). |
22 GO annotations of biological process
Name | Definition |
---|---|
activation of GTPase activity | Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP. |
B cell proliferation | The expansion of a B cell population by cell division. Follows B cell activation. |
cell differentiation | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
inflammatory response to antigenic stimulus | An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes. |
mast cell degranulation | The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell. |
natural killer cell activation | The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
positive regulation of granulocyte macrophage colony-stimulating factor production | Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production. |
positive regulation of JNK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
positive regulation of natural killer cell activation | Any process that activates or increases the frequency, rate or extent of natural killer cell activation. |
positive regulation of natural killer cell differentiation | Any process that activates or increases the frequency, rate or extent of natural killer cell differentiation. |
positive regulation of natural killer cell mediated cytotoxicity | Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of Ras protein signal transduction | Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction. |
positive regulation of T cell differentiation in thymus | Any process that activates or increases the frequency, rate or extent of T cell differentiation in the thymus. |
positive regulation of tumor necrosis factor production | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
positive regulation of type II interferon production | Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
Ras protein signal transduction | The series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that modulates the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
secretory granule localization | Any process in which a secretory granule is transported to, and/or maintained in, a specific location within the cell. |
T cell proliferation | The expansion of a T cell population by cell division. Follows T cell activation. |
vesicle transport along microtubule | The directed movement of a vesicle along a microtubule, mediated by motor proteins. This process begins with the attachment of a vesicle to a microtubule, and ends when the vesicle reaches its final destination. |
28 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A6N9I4 | RASGRP2 | RAS guanyl-releasing protein 2 | Bos taurus (Bovine) | SS |
Q1LZ97 | RASGRP4 | RAS guanyl-releasing protein 4 | Bos taurus (Bovine) | SS |
A0A3S5ZPR1 | RASGRP3 | RAS guanyl releasing protein 3 | Gallus gallus (Chicken) | SS |
P26675 | Sos | Protein son of sevenless | Drosophila melanogaster (Fruit fly) | SS |
Q07890 | SOS2 | Son of sevenless homolog 2 | Homo sapiens (Human) | SS |
Q5JS13 | RALGPS1 | Ras-specific guanine nucleotide-releasing factor RalGPS1 | Homo sapiens (Human) | PR |
Q86X27 | RALGPS2 | Ras-specific guanine nucleotide-releasing factor RalGPS2 | Homo sapiens (Human) | PR |
Q13905 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | Homo sapiens (Human) | PR |
Q07889 | SOS1 | Son of sevenless homolog 1 | Homo sapiens (Human) | EV |
Q8TDF6 | RASGRP4 | RAS guanyl-releasing protein 4 | Homo sapiens (Human) | SS |
Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | Homo sapiens (Human) | EV SS |
Q8IV61 | RASGRP3 | Ras guanyl-releasing protein 3 | Homo sapiens (Human) | SS |
O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | Homo sapiens (Human) | EV |
Q02384 | Sos2 | Son of sevenless homolog 2 | Mus musculus (Mouse) | SS |
Q62245 | Sos1 | Son of sevenless homolog 1 | Mus musculus (Mouse) | SS |
Q8VCC8 | Rapgef3 | Rap guanine nucleotide exchange factor 3 | Mus musculus (Mouse) | SS |
Q9EQZ6 | Rapgef4 | Rap guanine nucleotide exchange factor 4 | Mus musculus (Mouse) | EV |
Q9D300 | Rasgef1c | Ras-GEF domain-containing family member 1C | Mus musculus (Mouse) | PR |
Q03385 | Ralgds | Ral guanine nucleotide dissociation stimulator | Mus musculus (Mouse) | PR |
Q8BTM9 | Rasgrp4 | RAS guanyl-releasing protein 4 | Mus musculus (Mouse) | SS |
Q9QUG9 | Rasgrp2 | RAS guanyl-releasing protein 2 | Mus musculus (Mouse) | SS |
Q9ERD6 | Ralgps2 | Ras-specific guanine nucleotide-releasing factor RalGPS2 | Mus musculus (Mouse) | PR |
A2AR50 | Ralgps1 | Ras-specific guanine nucleotide-releasing factor RalGPS1 | Mus musculus (Mouse) | PR |
P0C643 | Rasgrp2 | RAS guanyl-releasing protein 2 | Rattus norvegicus (Rat) | SS |
Q8R5I4 | Rasgrp4 | RAS guanyl-releasing protein 4 | Rattus norvegicus (Rat) | SS |
Q9R1K8 | Rasgrp1 | RAS guanyl-releasing protein 1 | Rattus norvegicus (Rat) | SS |
Q9N5D3 | sos-1 | Son of sevenless homolog | Caenorhabditis elegans | EV |
A4IJ06 | rasgrp1 | RAS guanyl-releasing protein 1 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MGTLGKAREA | PRKPCHGSRA | GPKARLEAKS | TNSPLPAQPS | LAQITQFRMM | VSLGHLAKGA |
70 | 80 | 90 | 100 | 110 | 120 |
SLDDLIDSCI | QSFDADGNLC | RNNQLLQVML | TMHRIIISSA | ELLQKVMNLY | KDALEKNSPG |
130 | 140 | 150 | 160 | 170 | 180 |
VCLKICYFVR | YWITEFWIMF | KMDASLTSTM | EEFQDLVKAN | GEETHCHLID | TTQINSRDWS |
190 | 200 | 210 | 220 | 230 | 240 |
RKLTQRIKSN | TSKKRKVSLL | FDHLEPEELS | EHLTYLEFKS | FRRISFSDYQ | NYLVNSCVKE |
250 | 260 | 270 | 280 | 290 | 300 |
NPTMERSIAL | CNGISQWVQL | MVLSRPTPQL | RAEVFIKFIH | VAQKLHQLQN | FNTLMAVIGG |
310 | 320 | 330 | 340 | 350 | 360 |
LCHSSISRLK | ETSSHVPHEI | NKVLGEMTEL | LSSCRNYDNY | RRAYGECTHF | KIPILGVHLK |
370 | 380 | 390 | 400 | 410 | 420 |
DLISLYEAMP | DYLEDGKVNV | QKLLALYNHI | NELVQLQEMA | PPLDANKDLV | HLLTLSLDLY |
430 | 440 | 450 | 460 | 470 | 480 |
YTEDEIYELS | YAREPRNHRA | PPLTPSKPPV | VVDWASGVSP | KPDPKTISKH | VQRMVDSVFK |
490 | 500 | 510 | 520 | 530 | 540 |
NYDLDQDGYI | SQEEFEKIAA | SFPFSFCVMD | KDREGLISRD | EITAYFMRAS | SIYSKLGLGF |
550 | 560 | 570 | 580 | 590 | 600 |
PHNFQETTYL | KPTFCDNCAG | FLWGVIKQGY | RCKDCGMNCH | KQCKDLVVFE | CKKRIKSPAI |
610 | 620 | 630 | 640 | 650 | 660 |
STENISSVVP | MSTLCPLGTK | DLLHAPEEGS | FIFQNGEIVD | HSEESKDRTI | MLLGVSSQKI |
670 | 680 | 690 | 700 | 710 | 720 |
SVRLKRTVAH | KSTQTESFPW | VGGETTPGHF | VLSSPRKSAQ | GALYVHSPAS | PCPSPALVRK |
730 | 740 | 750 | 760 | 770 | 780 |
RAFVKWENKE | SLIKPKPELH | LRLRTYQELE | QEINTLKADN | DALKIQLKYA | QKKIESLQLG |
790 | |||||
KSNHVLAQMD | HGDSA |